Market revenue in 2021 | USD 480.2 million |
Market revenue in 2028 | USD 636.4 million |
Growth rate | 4.1% (CAGR from 2021 to 2028) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | CareSens Expert Plus |
Historical data covered | 2016 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 48.08% in 2021. Horizon Databook has segmented the North America network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
North America generated the highest revenue in global Point-Of-Care (nPOC) glucose diagnostics/testing market in 2019 and is expected to maintain its dominance over the forecast period. This region is home to several key market players such as Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC.
This has increased availability of glucose testing products, thereby contributing to the revenue generation. In addition, higher healthcare expenditure by governments on diabetes management is one of the factors responsible for the largest share held by the region in the global market.
Furthermore, local manufacturers are continuously evolving in terms of technological advancements and are incorporating latest technologies, such as Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR), which is expected to drive the market growth during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America network point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account